Polyrizon Ltd. (PLRZ)
PLRZ Stock Price Chart
Explore Polyrizon Ltd. interactive price chart. Choose custom timeframes to analyze PLRZ price movements and trends.
PLRZ Company Profile
Discover essential business fundamentals and corporate details for Polyrizon Ltd. (PLRZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Oct 2024
Employees
2.00
CEO
Tomer Izraeli
Description
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
PLRZ Financial Timeline
Browse a chronological timeline of Polyrizon Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 1 Jul 2026
Earnings released on 25 Mar 2026
EPS came in at -$1.96 .
Stock split effective on 28 Nov 2025
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 27 May 2025
Shares were split 1 : 250 , changing the number of shares outstanding and the price per share accordingly.
PLRZ Stock Performance
Access detailed PLRZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
